Mechanisms of corneal allergic reaction: new options for treatment

References

• Tuft SJ, Kemeny DM, Dart JK, Buckley RJ. Clinical features of atopic keratoconjunctivitis. Ophthalmology98(2), 150–158 (1991).
   PubMed Web of Science ®Google Scholar
• Tabbara KF. Ocular complications of vernal keratoconjunctivitis. Can. J. Ophthalmol.34(2), 88–92 (1999).
   PubMed Web of Science ®Google Scholar
• Patel SP, Dana R. Corneal lymphangiogenesis: implications in immunity. Semin. Ophthalmol.24, 135–138 (2009).
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. Immune privilege in the anterior chamber of the eye. Crit. Rev. Immunol.22, 13–46 (2002).
   PubMed Web of Science ®Google Scholar
• Hamrah P, Dana MR. Corneal antigen-presenting cells. Chem. Immunol. Allergy92, 58–70 (2007).
   PubMedGoogle Scholar
• Hamrah P, Huq SO, Liu Y et al. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J. Leukoc. Bio.74, 172–178 (2003).
   PubMed Web of Science ®Google Scholar
• Bacon AS, Tuft SJ, Metz DM et al. The origin of keratopathy in chronic allergic eye disease: a histopathological study. Eye7(Suppl.), 21–25 (1993).
   PubMed Web of Science ®Google Scholar
• Leonardi A, DeFranchis G, Zancanaro F et al. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest. Ophthalmol. Vis. Sci.40, 3036–3040 (1999).
   PubMed Web of Science ®Google Scholar
• Leonardi A, Motterle L, Bortolotti M. Allergy and the eye. Clin. Exp. Immunol.153, S17–S21 (2008).
   PubMed Web of Science ®Google Scholar
• Kumagai N, Fukuda K, Fujitsu Y et al. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog. Retin. Eye Res.25, 165–187 (2006).
   PubMed Web of Science ®Google Scholar
• Tanaka M, Dogru M, Takano Y et al. The relation of conjunctival and corneal findings in severe ocular allergies. Cornea23, 464–467 (2004).
   PubMed Web of Science ®Google Scholar
• Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergology Int.57, 121–134 (2008).
   PubMedGoogle Scholar
• Leonardi A, Brun P, Abatangelo G et al. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest. Ophthalmol. Vis. Sci.44, 3052–3058 (2003).
   PubMed Web of Science ®Google Scholar
• Messmer EM, May CA, Stefani FH et al. Toxic eosinophil granule protein deposition in corneal ulcerations and scars associated with atopic keratoconjunctivitis. Am. J. Ophthalmol.134, 816–821 (2002).
   PubMed Web of Science ®Google Scholar
• Trocme SD, Kephart GM, Allansmith MR et al. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am. J. Ophthalmol.108, 57–63 (1989).
   PubMed Web of Science ®Google Scholar
• Leonardi A, Jose P, Zhan et al. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology110, 487–492 (2003).
   PubMed Web of Science ®Google Scholar
• Avunduk AM, Avunduk MC, Dayanir V, Tekelioglu Y, Dayioglu YS. A flow cytometric study about the immunopathology of vernal keratoconjunctivitis. J. Allergy Clin. Immunol.101, 821–824 (1998).
   PubMedGoogle Scholar
• Saitou T, Fukuchi T, Tazawa H, Sakaue F, Sawaguchi S, Iwata K. Histopathology of corneal plaque in vernal keratoconjunctivitis. Nippon Ganka Gakkai Zasshi.97, 201–209 (1993).
   PubMedGoogle Scholar
• Inatomi T, Spurr-Michaud S, Tisdale A, Zhan Q. Expression of secretory mucin genes by humans. Invest. Ophthalmol. Vis. Sci.37, 1684–1692 (1996).
   PubMed Web of Science ®Google Scholar
• Dogru M, Okada N, Asano-Kato N et al. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr. Eye Res.30, 897–905 (2005).
   PubMed Web of Science ®Google Scholar
• Dogru M, Matsumoto Y, Okada N et al. Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy63, 1324–1334 (2008).
   PubMed Web of Science ®Google Scholar
• Dogru M, Okada N, Asano-Kato N et al. Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis. Clin. Exp. Allergy36, 1556–1565 (2006).
   PubMedGoogle Scholar
• Dogru M, Ozmen A, Ertürk H, Sanli O, Karatas A. Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivitis: an open-label study. Clin. Ther.24(8), 1309–1321 (2002).
   PubMed Web of Science ®Google Scholar
• Hu Y, Matsumoto Y, Adan ES et al. Corneal in vivo confocal scanning laser microscopy in patients with atopic keratoconjunctivitis. Ophthalmology15(11), 2004–2412 (2008).
   Google Scholar
• Sack R, Conradi L, Beaton A, Sathe S, McNamara N, Leonardi A. Antibody array characterisation of inflammatory mediators in allergic and nomral tears in the open and closed eye environments. Exp. Eye Res.85, 528–538 (2007).
   PubMedGoogle Scholar
• Iqbal A, Jan S, Babar TF, Khan MD. Corneal complications of vernal catarrh. J. Coll. Physicians Surg. Pak.13(7), 394–397 (2003).
   PubMedGoogle Scholar
• Cameron JA. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology102, 985–993 (1995).
   PubMed Web of Science ®Google Scholar
• Shakiba Y, Mansouri K, Arshadi D, Rezaei N. Corneal neovascularization: molecular events and therapeutic options. Recent Pat. Inflamm. Allergy Drug. Discov.3, 221–231 (2009).
   PubMedGoogle Scholar
• Sangwan VS, Murthy SI, Vemuuganti GK, Bansal AK, Gangopadhyay N, Rao GN. Cultivated corneal epithelial transplantation for severe ocular surface disease in vernal keratoconjunctivitis. Cornea24, 426–430 (2005).
   PubMed Web of Science ®Google Scholar
• Hilgartner HL, Hilgartner HL Jr, Gilbert JT. A preliminary report of a case of keratoconus successfully treated with organotherapy, radium and shortwave diathermy. Am. J. Ophthalmol.20, 1032–1039 (1937).
   Google Scholar
• Weed KH, MacEwen CJ, Giles T, Low J, McGhee CN. The Dundee University Scottish Keratoconus study: demographics, corneal signs, associated diseases, and eye rubbing. Eye22(4), 534–541 (2008).
   PubMed Web of Science ®Google Scholar
• Gasset AR, Hinson WA, Frias JL. Keratoconus and atopic disease. Ann. Ophthalmol.10, 991–994 (1978).
   PubMed Web of Science ®Google Scholar
• Totan Y, Hepşen IF, Cekiç O et al. Incidence of keratoconus in subjects with vernal keratoconjunctivitis: a videokeratographic study. Ophthalmology108, 824–827 (2001).
   PubMed Web of Science ®Google Scholar
• Ebihara N, Funaki T, Matsuda H, Okumura K, Murakami A, Ra C. Corneal abnormalities in the NC/Nga mouse: an atopic dermatitis model. Cornea27, 923–929 (2008).
   PubMedGoogle Scholar
• Demirbas NH, Pflugfelder SC. Topographic pattern and apex location of keratoconus on elevation topography maps. Cornea17, 476–484 (1998).
   PubMed Web of Science ®Google Scholar
• Kaya V, Karakaya M, Utine CA et al. Evaluation of the corneal topographic characteristics of keratoconus with orbscan II in patients with and without atopy. Cornea26, 945–948 (2007).
   PubMed Web of Science ®Google Scholar
• Smith VA, Matthews FJ, Majid MA et al. Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation. Biochem. Biophys. Acta1762, 431–439 (2006).
   PubMed Web of Science ®Google Scholar
• Mackiewicz Z, Määttä M, Stenman M et al. Collagenolytic proteinases in keratoconus. Cornea25, 603–610 (2006).
   PubMed Web of Science ®Google Scholar
• Cameron JA, Al-Rajhi AA, Badr IA. Corneal ectasia in vernal keratoconjunctivitis. Ophthalmology96, 1615–1623 (1989).
   PubMed Web of Science ®Google Scholar
• Koulikovska M, van der Ploeg I, Herrmann B et al. Respiratory syncytial virus and chlamydia are not detectable by PCR in ongoing vernal keratoconjunctivitis. Ocul. Immunol. Inflamm.9, 253–257 (2001).
   PubMed Web of Science ®Google Scholar
• Baker BS. The role of microorganisms in atopic dermatitis. Clin. Exp. Immunol.144(1), 1–9 (2006).
   PubMed Web of Science ®Google Scholar
• Kaiserman I, Kaiserman N, Elhayany A et al. Increased risk for herpetic eye disease in patients with allergic conjunctivitis. Curr. Eye Res.31, 721–725 (2006).
   PubMed Web of Science ®Google Scholar
• Rezende RA, Hammersmith K, Bisol T et al. Comparative study of ocular herpes simplex virus in patients with and without self-reported atopy. Am. J. Ophthalmol.141(6), 1120–1125 (2006).
   PubMedGoogle Scholar
• Gedik S, Akova YA, Gür S. Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis. Cornea25, 974–976 (2006).
   PubMedGoogle Scholar
• Kerr N, Stern GA. Bacterial keratitis associated with vernal keratoconjunctivitis. Cornea11(4), 355–359 (1992).
   PubMed Web of Science ®Google Scholar
• Tanure MA, Cohen EJ, Sudesh S, Rapuano CJ, Laibson PR. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea19, 307–312 (2000).
   PubMed Web of Science ®Google Scholar
• Arora R, Gupta S, Raina UK et al. Penicillium keratitis in vernal keratoconjunctivitis. Indian J. Ophthalmol.50, 215–216 (2002).
   PubMedGoogle Scholar
• Sridhar MS, Gopinathan U, Rao GN. Fungal keratitis associated with vernal keratoconjunctivitis. Cornea22, 80–81 (2003).
   PubMedGoogle Scholar
• Lambiase A, Manni L, Bonini S et al. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest. Ophthalmol. Vis. Sci.41, 1063–1069 (2000).
   PubMed Web of Science ®Google Scholar
• Motterle L, Diebold Y, Enriquez de Salamanca A et al. Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. Arch. Ophthalmol.124, 462–468 (2006).
   PubMedGoogle Scholar
• Lambiase A, Minchiotti S, Leonardi A et al. Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population. Ophthal. Epidemiol.16, 38–41 (2009).
   PubMed Web of Science ®Google Scholar
• Leonardi A, Bremond-Gignac D, Bortolotti M et al. Clinical and biological efficacy of preservative free NAAGA eye-dorps versus levocabastine eye-drops in vernal keratoconjunctivitis patients. Br. J. Ophthalmol.91(12), 1662–1666 (2007).
   PubMed Web of Science ®Google Scholar
• Leonardi A, DeFranchis G, De Paoli M, Fregona I, Plebani M, Secchi A. Histamine induced cytokine production and ICAM-1 expression in human conjunctival fibroblasts. Curr. Eye Res.25(3), 189–196 (2002).
   PubMed Web of Science ®Google Scholar
• McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf.25, 33–55 (2002).
   PubMed Web of Science ®Google Scholar
• Garrott HM, Walland MJ. Glaucoma from topical corticosteroids to the eyelids. Clin. Exp. Ophthalmol.32(6), 656–657 (2004).
   Google Scholar
• Mantelli F, Santos MS, Petitti T et al. Systematic review and meta-analysis of randomized clinical trials on topical treatments for vernal keratoconjunctivitis. Br. J. Ophthalmol.91(12), 1656–1661 (2007).
   PubMed Web of Science ®Google Scholar
• Fukushima A. Roles of T-cells in the development of allergic conjunctival diseases. Cornea26, S36–S40 (2007).
   PubMedGoogle Scholar
• Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr. Opin. Allergy Clin. Immunol.7, 429–435 (2007).
   PubMed Web of Science ®Google Scholar
• Cetinkaya A, Akova YA, Dursun D et al. Topical cyclosporine in the management of shield ulcers. Cornea23, 194–200 (2004).
   PubMed Web of Science ®Google Scholar
• Daniell M, Constantinou M, Vu HT et al. Randomized controlled trial of cyclosporine A in steroid dependent allergic conjunctivitis. Br. J. Ophthalmol.90, 461–464 (2006).
   PubMed Web of Science ®Google Scholar
• Ozcan AA, Ersoz TR, Dulger E. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Cornea26, 1035–1038 (2007).
   PubMed Web of Science ®Google Scholar
• Akpek EK, Dart JK, Watson S et al. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology111, 476–482 (2004).
   PubMed Web of Science ®Google Scholar
• Ebihara N, Ohashi Y, Uchio E et al. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. J. Ocul. Pharmacol. Ther.25, 365–372 (2009).
   PubMed Web of Science ®Google Scholar
• Saito H, Kato A, Matsumoto K. Role of mast cells in allergy. Nippon Rinsho.67, 2083–2087 (2009).
   PubMedGoogle Scholar
• Atlas-Fox L, Barkanan Y, Ishakov V et al. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open label pilot study. Curr. Eye Res.33, 545–549 (2008).
   PubMedGoogle Scholar
• Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology115, 988–992 (2008).
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Ebihara N, Fujishima H et al. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J. Ocul. Pharmacol. Ther.26(2), 165–174 (2010).
   PubMed Web of Science ®Google Scholar
• Daniell M, Maini R, Tole D. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Clin. Exp. Ophthalmol.30, 94–98 (2002).
   PubMed Web of Science ®Google Scholar
• Akpek EK, Hasiripi H, Christen WG, Kalayci D. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis. Ophthalmology107, 263–269 (2000).
   PubMed Web of Science ®Google Scholar
• Tanaka M, Takano Y, Dogru M et al. A comparative evaluation of the efficacy of intraoperative mitomycin-C use after the excision of cobblestone-like papillae in severe atopic and vernal keratoconjunctivitis. Cornea23, 326–329 (2004).
   PubMed Web of Science ®Google Scholar
• van Wijngaarden P, Coster DJ, Williams KA. Inhibitors of ocular neovascularization: promises and potential problems. JAMA293, 1509–1513 (2005).
   PubMed Web of Science ®Google Scholar
• Fuurer E, Berdugo M, Stellar C et al. Pharmacokinetics and posterior segment biodistrobutiuon of ESBA~105, an anti-TNF-α single chain antiody, upon otpical administration to the rabbit eye. Invest. Ophth. Vis. Sci.50, 771–778 (2009).
   PubMedGoogle Scholar
• Bock F, Onderka J, Dietrich T et al. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest. Ophthalmol. Vis. Sci.48, 2545–2552 (2007).
   PubMed Web of Science ®Google Scholar
• Kim TI, Chung JL, Hong JP, Min K, Seo KY, Kim EK. Bevacizumab application delays epithelial healing in rabbit cornea. Invest. Ophthalmol. Vis. Sci.50, 4653–4659 (2009).
   PubMed Web of Science ®Google Scholar
• Brightling C, Berry M, Amrani Y. Targeting TNF-α: a novel therapeutic approach for asthma. J. Allergy Clin. Immunol.121, 5–10 (2008).
   PubMed Web of Science ®Google Scholar
• Belloni B, Andres C, Ollert M, Ring J, Mempel M. Novel immunological approaches in the treatment of atopic eczema. Curr. Opin. Allergy Clin. Immunol.8, 423–427 (2008).
   PubMedGoogle Scholar
• Ottiger M, Thiel MA, Feige U, Lichtlen P, Urech DM. Efficient intraocular penetration of topical anti-TNF-α single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer. Invest. Ophthalmol. Vis. Sci.50, 779–786 (2009).
   PubMed Web of Science ®Google Scholar
• Korn S, Thielen A, Seyfried S, Taube C, Kornmann O, Buhl R. Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany. Respir. Med.103, 1725–1731 (2009).
   PubMed Web of Science ®Google Scholar
• Rolinck-Werninghaus C, Hamelman E, Keil T et al. The co-seasonal application of anti-IgE after pre-seasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy59, 973–979 (2004).
   PubMed Web of Science ®Google Scholar
• Röder E, Berger MY, de Groot H, van Wijk RG. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr. Allergy Immunol.19, 197–207 (2008).
   PubMed Web of Science ®Google Scholar
• Akdis M, Akdis CA. Therapeutic manipulation of immune tolerance in allergic disease. Nat. Rev. Drug Discov.8, 645–660 (2009).
   PubMed Web of Science ®Google Scholar
• Rolland JM, Gardner LM, O’Hehir RE. Allergen-related approaches to immunotherapy. Pharmacol. Ther.121, 273–284 (2009).
   PubMed Web of Science ®Google Scholar
• Williams KA, Lowe M, Bartlett C, Kelly TL, Coster DJ; All Contibutors. Rick factors for human corneal graft failure within the Australian corneal graft registry. Transplantation86, 1720–1724 (2008).
   PubMed Web of Science ®Google Scholar
• Power WJ, Tugal-Tutkun I, Foster CS. Long-term follow-up of patients with atopic keratoconjunctivitis. Ophthalmology105, 637–642 (1998).
   PubMed Web of Science ®Google Scholar
• Pelegrin L, Gris O, Adán A et al. Superficial keratectomy and amniotic membrane patch in the treatment of corneal plaque of vernal keratoconjunctivitis. Eur. J. Ophthalmol.18, 131–133 (2008).
   PubMedGoogle Scholar